Key details
Sponsor
Middle East North Africa Stroke and Interventional Neurotherapies Organization
Enrollment target
~150 participants
Primary completion
August 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 60 Years
Last updated November 2024